Gilead Sciences, Inc. (GILD): Dividends Paid
$4.00B
Year ended 2025-12-31
$4.07B
Trailing 12 months to 2026-06-30
+2.6%
3-year compound annual growth
+3.0%
5-year compound annual growth
+7.9%
10-year compound annual growth
| Period ended | Dividends Paid | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.00B | +2.2% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $3.92B | +2.9% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $3.81B | +2.7% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $3.71B | +2.9% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $3.60B | +4.5% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $3.45B | +7.0% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $3.22B | +8.4% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $2.97B | +8.8% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $2.73B | +11.2% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $2.46B | +31.0% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $1.87B | n/a | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $0 | n/a | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | $0 | n/a | 2016-02-24, From 2013-01-01 |
Dividends Paid at similar companies
| Company | Year ended | Dividends Paid | Change YoY |
|---|---|---|---|
| Gilead Sciences, Inc. (GILD) | 2025-12-31 | $4.00B | +2.2% |
| Amgen Inc (AMGN) | 2025-12-31 | $5.12B | +6.0% |
| Qiagen N.V. (QGEN) | 2025-12-31 | $54.24M | n/a |
| Bio-Techne Corp (TECH) | 2026-06-30 | $49.92M | -0.9% |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $0 | n/a |
| Scilex Holding Co (SCLX) | 2024-12-31 | $8.65M | 0.0% |
| Viskase Holdings, Inc. (VISK) | 2025-12-31 | $1.27M | 0.0% |
| Windtree Therapeutics Inc (WINT) | 2024-12-31 | $657.0K | n/a |
| Vor Biopharma Inc. (VOR) | 2025-12-31 | $0 | n/a |
Compare GILD, AMGN, QGEN, TECH side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗